Concepedia

Lingtian Zhang

LZ

Statistics

Publications

13

Citations

321

H-Index

12

Active since

2015

Affiliations

University of Arkansas for Medical Sciences(Current)

University of Naples Federico II

Institute for Experimental Endocrinology and Oncology

Birkbeck, University of London

University of California, San Francisco

Lingtian Zhang is an author at University of Arkansas for Medical Sciences specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2015–2022

13

Publications

13

Discovery of SP-96, the first non-ATP-competitive Aurora Kinase B inhibitor, for reduced myelosuppression

Naga Rajiv Lakkaniga, Lingtian Zhang, Binyam Belachew et al. · European Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

, , +5

Catalyst free, C-3 functionalization of imidazo[1,2-<i>a</i>]pyridines to rapidly access new chemical space for drug discovery efforts

Gunaganti Naresh, Anupreet Kharbanda, Naga Rajiv Lakkaniga et al. · Chemical Communications · 2018 · 37 citations · Full text

, , +14

Screening the key genes of hair follicle growth cycle in Inner Mongolian Cashmere goat based on RNA sequencing

Rui Su, Gao Gong, Lingtian Zhang et al. · Archives animal breeding/Archiv für Tierzucht · 2020 · 34 citations · Full text

, , +7

Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation

Naga Rajiv Lakkaniga, Gunaganti Naresh, Lingtian Zhang et al. · European Journal of Medicinal Chemistry · 2020 · 29 citations · Full text

, , +9

Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology

Marialuisa Moccia, Brendan Frett, Lingtian Zhang et al. · Journal of Medicinal Chemistry · 2020 · 27 citations · Full text

, , +14

1–5 of 13